M
MetaVia Inc. Common StockMTVA
MetaVia Inc. is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. The company is currently developing DA-1726 for the treatment of obesity, and is developing vanoglipel (DA-1241) for the treatment of Metabolic Dysfunction-Associated Steatohepatitis.
US StocksHealthcareSmall CapBiotechnology
MTVA 가격 추세
MetaVia Inc. Common Stock · TradingView 전체 차트
NASDAQ:MTVA